Does Insulet (PODD) Elevate Its Diabetes Tech Edge With Panos Steering Global Commercial Strategy? [Yahoo! Finance]
Insulet Corporation (PODD)
Last insulet corporation earnings: 2/25 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.insulet.com/investor-relations
Company Research
Source: Yahoo! Finance
This leadership change comes on the heels of strong quarterly results powered by Insulet's tubeless Pod insulin technology, underscoring an effort to strengthen commercial capabilities as diabetes technology gains momentum. Now we'll assess how Panos's appointment to lead Insulet's global commercial organization could influence the company's investment narrative and growth focus. The latest GPUs need a type of rare earth metal called Neodymium and there are only 26 companies in the world exploring or producing it . Find the list for free. Insulet Investment Narrative Recap For Insulet, the core belief is that its Omnipod platform can keep gaining share in diabetes care while supporting healthier profitability over time. The key near term catalyst remains execution on Omnipod 5 adoption and type 2 diabetes penetration, and Mike Panos's appointment looks aligned with that focus rather than a material change in direction. The biggest risk still centers on concentrated dependence
Show less
Read more
Impact Snapshot
Event Time:
PODD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PODD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PODD alerts
High impacting Insulet Corporation news events
Weekly update
A roundup of the hottest topics
PODD
News
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insulet Corporation - PODDPR Newswire
- PODD Investor Alert: Insulet Corp. Potential Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Executives Allegedly Misled on Safety: Levi & KorsinskyGlobeNewswire
- Insulet (PODD) had its price target lowered by Truist Financial Corporation from $360.00 to $315.00. They now have a "buy" rating on the stock.MarketBeat
- PODD Investor Alert: Insulet Corp. Potential Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Company Allegedly Concealed Device Defect: Levi & KorsinskyPR Newswire
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insulet Corporation - PODDGlobeNewswire
PODD
Earnings
- 2/18/26 - Beat
PODD
Sec Filings
- 4/6/26 - Form DEFA14A
- 4/6/26 - Form DEF
- 4/2/26 - Form 4
- PODD's page on the SEC website